Inactive Instrument

Analyst Reco. Vifor Pharma Deutsche Boerse AG

Equities

G2AA

CH0364749348

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Fitch Pulls Vifor Pharma's Rating After CSL Takeover	25/08/22	MT
Fitch Puts Vifor Pharma on Rating Watch Positive on CSL Takeover	16/06/22	MT
Octavian Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	14/12/21	MT
Oddo BHF Lifts Price Target on Vifor Pharma, Downgrades Recommendation to Neutral	14/12/21	MT
AlphaValue/Baader Europe Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	07/12/21	MT
ANALYST RECOMMENDATIONS : Amazon, AMD, Bank of America, Intel, Boeing...	01/11/21
ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...	20/09/21
VIFOR PHARMA : Bank Vontobel Lifts Price Target on Vifor Pharma, Maintains Hold Recommendation	25/08/21	MT
VIFOR PHARMA : Credit Suisse Lifts Price Target on Vifor Pharma, Maintains Outperform Recommendation	25/08/21	MT
ANALYST RECOMMENDATIONS : AMC, AMD, Greggs, Roku, Tesla...	09/08/21
ANALYST RECOMMENDATIONS : Avast, Asos, Compass, Halliburton, Intertek...	21/07/21
VIFOR PHARMA : AlphaValue/Baader Europe Lowers Price Target on Vifor Pharma, Maintains Buy Recommendation	29/06/21	MT
VIFOR PHARMA : AlphaValue/Baader Europe Lifts Price Target on Vifor Pharma, Upgrades Recommendation to Buy from Add	28/06/21	MT
ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...	25/06/21
VIFOR PHARMA : Research Partners Downgrades Recommendation on Vifor Pharma To Sell From Hold, Lowers Price Target	24/06/21	MT
VIFOR PHARMA : Research Partners Lowers Price Target on Vifor Pharma, Maintains Hold Recommendation	06/05/21	MT
VIFOR PHARMA : Mirabaud Securities Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	08/03/21	MT
Vifor Pharma : Fitch Confirms Vifor Pharma at BBB-, Keeps Outlook Stable	01/03/21	MT
VIFOR PHARMA : Octavian Lowers Price Target on Vifor Pharma, Maintains Buy Recommendation	30/11/20	MT
VIFOR PHARMA : Research Partners Maintains Price Target on Vifor Pharma, Initiates Coverage With Hold Recommendation	23/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Vifor Pharma Deutsche Boerse AG

Equities

G2AA

CH0364749348

Analyst Reco.

Filters